Factors contributing to the prognostic significance of bone marrow involvement in childhood non-Hodgkin lymphoma
- 1 January 1994
- journal article
- research article
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 23 (4) , 350-353
- https://doi.org/10.1002/mpo.2950230406
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- LSA2-L2 protocol treatment of stage IV non-hodgkin's lymphoma in children with partial and extensive bone marrow involvementCancer, 2006
- Non-Hodgkin's lymphomas of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institution.Journal of Clinical Oncology, 1989
- Bone marrow involvement in young patients with non‐Hodgkin's lymphoma: The importance of multiple bone marrow samples for accurate stagingMedical and Pediatric Oncology, 1989
- Importance Sampling for Estimating Exact Probabilities in Permutational InferenceJournal of the American Statistical Association, 1988
- Pediatric oncology group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded)Cancer, 1985
- An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adultsBlood, 1984
- Childhood Non-Hodgkin's LymphomaNew England Journal of Medicine, 1983
- Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP)Cancer, 1982
- National cancer institute sponsored study of classifications of non-hodgkin's lymphomas. Summary and description of a working formulation for clinical usageCancer, 1982
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958